[
    [
        {
            "time": "2021-02-10",
            "original_text": "Thermo Fisher's Oncomine Dx Gets CDx Approval From MHLW",
            "features": {
                "keywords": [
                    "Thermo Fisher",
                    "Oncomine Dx",
                    "CDx",
                    "MHLW"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Thermo Fisher's Oncomine Dx Gets CDx Approval From MHLW",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-21",
            "original_text": "After Regeneron, US Government Orders Additional COVID-19 Therapy From Eli Lilly",
            "features": {
                "keywords": [
                    "Regeneron",
                    "US Government",
                    "Eli Lilly",
                    "COVID-19",
                    "therapy"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "After Regeneron, US Government Orders Additional COVID-19 Therapy From Eli Lilly",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-22",
            "original_text": "The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs",
            "features": {
                "keywords": [
                    "Lilly",
                    "Regeneron",
                    "COVID-19",
                    "drug deal",
                    "Calliditas",
                    "Theravance",
                    "IPOs"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-25",
            "original_text": "UPDATE 1-U.S. buys additional doses of Eli Lilly, Regeneron COVID-19 therapy",
            "features": {
                "keywords": [
                    "U.S.",
                    "Eli Lilly",
                    "Regeneron",
                    "COVID-19",
                    "therapy"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "UPDATE 1-U.S. buys additional doses of Eli Lilly, Regeneron COVID-19 therapy",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-26",
            "original_text": "Eli Lilly to supply the U.S. government with doses of COVID-19 treatment etesevimab for $330 million",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "U.S. government",
                    "COVID-19",
                    "etesevimab",
                    "$330 million"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly to supply the U.S. government with doses of COVID-19 treatment etesevimab for $330 million",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-01-27",
            "original_text": "Lilly to supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19",
            "features": {
                "keywords": [
                    "Lilly",
                    "388,000 doses",
                    "etesevimab",
                    "U.S. government",
                    "COVID-19"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly to supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        }
    ]
]